National Childhood Vaccine Injury Act of 1986

Target entity: National Childhood Vaccine Injury Act of 1986
Context triple: [Office of Special Masters of the U.S. Court of Federal Claims, legalBasis, National Childhood Vaccine Injury Act of 1986]

• A. Kefauver–Harris Drug Amendments of 1962
  The Kefauver–Harris Drug Amendments of 1962 are U.S. federal regulations that strengthened drug safety and efficacy requirements, mandating proof of effectiveness and stricter oversight of pharmaceutical marketing and manufacturing.
• B. Orphan Drug Act of 1983
  The Orphan Drug Act of 1983 is a U.S. law that incentivizes the development of treatments for rare diseases by offering benefits such as market exclusivity, tax credits, and research grants to drug manufacturers.
• C. Public Law 91-76
  Public Law 91-76 is the U.S. federal statute enacted in 1969 that established the Congressional Space Medal of Honor to recognize extraordinary contributions to the nation’s space programs.
• D. False Claims Amendments Act of 1986
  The False Claims Amendments Act of 1986 is a major U.S. federal law that strengthened the government’s ability to combat fraud against federal programs by expanding whistleblower (qui tam) provisions and increasing penalties for false claims.
• E. Drug Price Competition and Patent Term Restoration Act of 1984
  The Drug Price Competition and Patent Term Restoration Act of 1984, commonly known as the Hatch-Waxman Act, is a U.S. law that streamlined the approval of generic drugs while providing patent term extensions to brand-name drug manufacturers to balance innovation and competition.
• F. None of above. chosen
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Target entity: National Childhood Vaccine Injury Act of 1986
Target entity description: The National Childhood Vaccine Injury Act of 1986 is a U.S. federal law that created a no-fault compensation program for individuals allegedly injured by certain vaccines and established a specialized legal framework for handling such claims.

• A. Kefauver–Harris Drug Amendments of 1962
  The Kefauver–Harris Drug Amendments of 1962 are U.S. federal regulations that strengthened drug safety and efficacy requirements, mandating proof of effectiveness and stricter oversight of pharmaceutical marketing and manufacturing.
• B. Orphan Drug Act of 1983
  The Orphan Drug Act of 1983 is a U.S. law that incentivizes the development of treatments for rare diseases by offering benefits such as market exclusivity, tax credits, and research grants to drug manufacturers.
• C. Public Law 91-76
  Public Law 91-76 is the U.S. federal statute enacted in 1969 that established the Congressional Space Medal of Honor to recognize extraordinary contributions to the nation’s space programs.
• D. False Claims Amendments Act of 1986
  The False Claims Amendments Act of 1986 is a major U.S. federal law that strengthened the government’s ability to combat fraud against federal programs by expanding whistleblower (qui tam) provisions and increasing penalties for false claims.
• E. Drug Price Competition and Patent Term Restoration Act of 1984
  The Drug Price Competition and Patent Term Restoration Act of 1984, commonly known as the Hatch-Waxman Act, is a U.S. law that streamlined the approval of generic drugs while providing patent term extensions to brand-name drug manufacturers to balance innovation and competition.
• F. None of above. chosen